PB

Piyush Bhanu

Director DIN 08179288
DIN 08179288 First appointment Jul 2018
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Piyush Bhanu

Data last updated:

Piyush Bhanu was a Director at Xome Life Sciences Private Limited (from 2020) and Managing Director at Themovos Enterprises Private Limited (from 2018).

DIN 08179288
First Appointment 13 Jul 2018
Oldest Company Age 8 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Xome Life Sciences Private Limited U74999KA2020PTC136639
Director29 Jul 20202020Strike Off
Themovos Enterprises Private Limited U01100BR2018PTC038710
Managing Director13 Jul 20182018Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Xome Life Sciences Private Limited
Themovos Enterprises Private Limited
Premium access

Shareholding and investment profile for Piyush Bhanu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Piyush Bhanu

Piyush Bhanu was first appointed on 13 Jul 2018 as Managing Director at Themovos Enterprises Private Limited. The most recent appointment on record is 29 Jul 2020 at Xome Life Sciences Private Limited.

Piyush Bhanu held 2 earlier board appointments: Xome Life Sciences Private Limited (Director, from 29 Jul 2020); Themovos Enterprises Private Limited (Managing Director, from 13 Jul 2018).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available